LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,277,151 | -21.1% | 1,344,010 | -18.9% | 0.02% | -18.2% |
| Q2 2023 | $114,441,454 | +35.0% | 1,657,851 | -5.7% | 0.02% | +29.4% |
| Q1 2023 | $84,743,177 | -6.4% | 1,757,428 | -3.1% | 0.02% | -5.6% |
| Q4 2022 | $90,492,479 | +34.2% | 1,812,750 | +9.7% | 0.02% | +28.6% |
| Q3 2022 | $67,442,000 | -53.0% | 1,652,965 | -36.6% | 0.01% | -51.7% |
| Q2 2022 | $143,468,000 | +51.3% | 2,608,488 | -0.1% | 0.03% | +81.2% |
| Q1 2022 | $94,841,000 | -10.6% | 2,609,818 | +14.6% | 0.02% | -5.9% |
| Q4 2021 | $106,134,000 | +254.2% | 2,277,045 | +284.2% | 0.02% | +240.0% |
| Q3 2021 | $29,964,000 | +127.6% | 592,635 | +39.0% | 0.01% | +66.7% |
| Q3 2020 | $13,166,000 | -50.0% | 426,484 | -31.0% | 0.00% | -50.0% |
| Q2 2020 | $26,310,000 | – | 618,223 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |